Sh6,000.00
Amoxiclav syrup 228/5, also known as Indiclav, is a combination medication that contains two active ingredients: amoxicillin and clavulanic acid. It is used to treat bacterial infections caused by susceptible organisms.
Some common uses of amoxiclav syrup 228/5 include:
| Settings | AMOXYCLAV SYR 228/5 INFUMOX 100ML remove | Alatrol Syrup 30ml remove | Acefen Tablets remove | Apdyl H Syrup remove | Vitamin E caps ENAT 400 remove | Action Tablets remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh6,000.00 | Sh2,000.00 | Sh6,000.00 | Sh2,500.00 | Sh23,000.00 | Sh10,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description | Amoxiclav syrup 228/5, also known as Indiclav, is a combination medication that contains two active ingredients: amoxicillin and clavulanic acid. It is used to treat bacterial infections caused by susceptible organisms. |
| ||||
| Content | Some common uses of amoxiclav syrup 228/5 include:
| Alatrol Syrup contains Cetirizine which is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. | Acefen Tablet is a combination of Ibuprofen and Paracetamol, a pain-relieving medicine. | APDYL medication is used to relieve coughs, common cold, bronchitis, and other breathing illnesses. Do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor expectorant, cough, cold | ENAT 400 is used for the prevention and treatment of vitamin E deficiency. ENAT 400 is used for the prevention and treatment of vitamin E deficiency. | Is a quality Aspirin, Paracetemol & Caffeine combination brand that promises quick relief from that pounding headache |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.